BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12783301)

  • 1. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.
    Sheth S; Shea JC; Bishop MD; Chopra S; Regan MM; Malmberg E; Walker C; Ricci R; Tsui LC; Durie PR; Zielenski J; Freedman SD
    Hum Genet; 2003 Aug; 113(3):286-92. PubMed ID: 12783301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
    Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
    Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sclerosing cholangitis is associated with abnormalities in CFTR.
    Werlin S; Scotet V; Uguen K; Audrezet MP; Cohen M; Yaakov Y; Safadi R; Ilan Y; Konikoff F; Galun E; Mizrahi M; Slae M; Sayag S; Cohen-Cymberknoh M; Wilschanski M; Ferec C
    J Cyst Fibros; 2018 Sep; 17(5):666-671. PubMed ID: 29807875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function.
    Pall H; Zielenski J; Jonas MM; DaSilva DA; Potvin KM; Yuan XW; Huang Q; Freedman SD
    J Pediatr; 2007 Sep; 151(3):255-9. PubMed ID: 17719933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.
    Henckaerts L; Jaspers M; Van Steenbergen W; Vliegen L; Fevery J; Nuytten H; Roskams T; Rutgeerts P; Cassiman JJ; Vermeire S; Cuppens H
    J Hepatol; 2009 Jan; 50(1):150-7. PubMed ID: 18992954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis.
    McGill JM; Williams DM; Hunt CM
    Dig Dis Sci; 1996 Mar; 41(3):540-2. PubMed ID: 8617131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis.
    Girodon E; Sternberg D; Chazouillères O; Cazeneuve C; Huot D; Calmus Y; Poupon R; Goossens M; Housset C
    J Hepatol; 2002 Aug; 37(2):192-7. PubMed ID: 12127423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.
    Clancy JP; Bebök Z; Ruiz F; King C; Jones J; Walker L; Greer H; Hong J; Wing L; Macaluso M; Lyrene R; Sorscher EJ; Bedwell DM
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1683-92. PubMed ID: 11401894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
    Groman JD; Meyer ME; Wilmott RW; Zeitlin PL; Cutting GR
    N Engl J Med; 2002 Aug; 347(6):401-7. PubMed ID: 12167682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.
    Cohn JA; Friedman KJ; Noone PG; Knowles MR; Silverman LM; Jowell PS
    N Engl J Med; 1998 Sep; 339(10):653-8. PubMed ID: 9725922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.
    Ziedalski TM; Kao PN; Henig NR; Jacobs SS; Ruoss SJ
    Chest; 2006 Oct; 130(4):995-1002. PubMed ID: 17035430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis.
    Gelrud A; Sheth S; Banerjee S; Weed D; Shea J; Chuttani R; Howell DA; Telford JJ; Carr-Locke DL; Regan MM; Ellis L; Durie PR; Freedman SD
    Am J Gastroenterol; 2004 Aug; 99(8):1557-62. PubMed ID: 15307877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data.
    Derichs N; Sanz J; Von Kanel T; Stolpe C; Zapf A; Tümmler B; Gallati S; Ballmann M
    Thorax; 2010 Jul; 65(7):594-9. PubMed ID: 20627915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis.
    Bishop MD; Freedman SD; Zielenski J; Ahmed N; Dupuis A; Martin S; Ellis L; Shea J; Hopper I; Corey M; Kortan P; Haber G; Ross C; Tzountzouris J; Steele L; Ray PN; Tsui LC; Durie PR
    Hum Genet; 2005 Dec; 118(3-4):372-81. PubMed ID: 16193325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.
    Sermet-Gaudelus I; Déchaux M; Vallée B; Fajac A; Girodon E; Nguyen-Khoa T; Marianovski R; Hurbain I; Bresson JL; Lenoir G; Edelman A
    Am J Respir Crit Care Med; 2005 May; 171(9):1026-31. PubMed ID: 15709055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials.
    Wilschanski M; Dupuis A; Ellis L; Jarvi K; Zielenski J; Tullis E; Martin S; Corey M; Tsui LC; Durie P
    Am J Respir Crit Care Med; 2006 Oct; 174(7):787-94. PubMed ID: 16840743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlating genotype with phenotype using CFTR-mediated whole-cell Cl
    Noel S; Servel N; Hatton A; Golec A; Rodrat M; Ng DRS; Li H; Pranke I; Hinzpeter A; Edelman A; Sheppard DN; Sermet-Gaudelus I
    J Physiol; 2022 Mar; 600(6):1515-1531. PubMed ID: 34761808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.